|
Gene: ZNF343 |
Gene summary for ZNF343 |
Gene summary. |
Gene information | Species | Human | Gene symbol | ZNF343 | Gene ID | 79175 |
Gene name | zinc finger protein 343 | |
Gene Alias | dJ734P14.5 | |
Cytomap | 20p13 | |
Gene Type | protein-coding | GO ID | GO:0000122 | UniProtAcc | Q6P1L6 |
Top |
Malignant transformation analysis |
Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells |
Malignant transformation involving gene list. |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
79175 | ZNF343 | LZE4T | Human | Esophagus | ESCC | 3.06e-21 | 5.31e-01 | 0.0811 |
79175 | ZNF343 | LZE24T | Human | Esophagus | ESCC | 1.46e-02 | 1.06e-01 | 0.0596 |
79175 | ZNF343 | P2T-E | Human | Esophagus | ESCC | 3.64e-15 | 1.13e-01 | 0.1177 |
79175 | ZNF343 | P8T-E | Human | Esophagus | ESCC | 3.03e-04 | 5.42e-02 | 0.0889 |
79175 | ZNF343 | P10T-E | Human | Esophagus | ESCC | 1.48e-13 | 1.00e-01 | 0.116 |
79175 | ZNF343 | P11T-E | Human | Esophagus | ESCC | 2.46e-02 | 1.16e-01 | 0.1426 |
79175 | ZNF343 | P12T-E | Human | Esophagus | ESCC | 3.37e-12 | 1.32e-01 | 0.1122 |
79175 | ZNF343 | P15T-E | Human | Esophagus | ESCC | 5.26e-03 | 8.41e-02 | 0.1149 |
79175 | ZNF343 | P16T-E | Human | Esophagus | ESCC | 1.42e-09 | 1.39e-01 | 0.1153 |
79175 | ZNF343 | P17T-E | Human | Esophagus | ESCC | 2.68e-03 | 1.43e-01 | 0.1278 |
79175 | ZNF343 | P20T-E | Human | Esophagus | ESCC | 2.18e-03 | 9.29e-02 | 0.1124 |
79175 | ZNF343 | P21T-E | Human | Esophagus | ESCC | 2.47e-04 | 8.58e-02 | 0.1617 |
79175 | ZNF343 | P22T-E | Human | Esophagus | ESCC | 9.42e-04 | 5.69e-02 | 0.1236 |
79175 | ZNF343 | P23T-E | Human | Esophagus | ESCC | 3.36e-03 | 9.60e-02 | 0.108 |
79175 | ZNF343 | P24T-E | Human | Esophagus | ESCC | 3.60e-05 | 6.68e-02 | 0.1287 |
79175 | ZNF343 | P26T-E | Human | Esophagus | ESCC | 5.21e-46 | 7.20e-01 | 0.1276 |
79175 | ZNF343 | P27T-E | Human | Esophagus | ESCC | 4.24e-04 | 4.51e-02 | 0.1055 |
79175 | ZNF343 | P28T-E | Human | Esophagus | ESCC | 2.11e-10 | 1.75e-01 | 0.1149 |
79175 | ZNF343 | P30T-E | Human | Esophagus | ESCC | 2.13e-03 | 1.46e-01 | 0.137 |
79175 | ZNF343 | P31T-E | Human | Esophagus | ESCC | 2.50e-06 | 8.93e-02 | 0.1251 |
Page: 1 2 3 |
Transcriptomic changes along malignancy continuum. |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer |
Figure of enriched GO biological processes. |
Tissue | Disease Stage | Enriched GO biological Processes |
Cervix | N_HPV | |
Endometrium | AEH | |
Endometrium | EEC | |
Prostate | BPH | |
Prostate | Tumor |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
Enriched GO biological processes. |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
Enriched KEGG pathways. |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
Annotation of somatic variants for genes involved in malignant transformation |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
ZNF343 | SNV | Missense_Mutation | novel | c.1795T>A | p.Phe599Ile | p.F599I | protein_coding | deleterious(0) | probably_damaging(0.935) | TCGA-A8-A06X-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
ZNF343 | SNV | Missense_Mutation | c.295C>T | p.Leu99Phe | p.L99F | protein_coding | tolerated(0.13) | benign(0.272) | TCGA-C8-A274-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Hormone Therapy | tamoxiphen | SD | ||
ZNF343 | SNV | Missense_Mutation | c.1786G>A | p.Gly596Ser | p.G596S | protein_coding | deleterious(0) | possibly_damaging(0.814) | TCGA-GM-A2D9-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Hormone Therapy | arimidex | SD | ||
ZNF343 | insertion | Frame_Shift_Ins | novel | c.1629_1630insGGGCCTCTTAGCTACTCCCC | p.Ser544GlyfsTer115 | p.S544Gfs*115 | protein_coding | TCGA-A2-A04V-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | cytoxan | PD | |||
ZNF343 | insertion | Frame_Shift_Ins | novel | c.1796_1797insC | p.Ser600Ter | p.S600* | protein_coding | TCGA-A8-A06X-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |||
ZNF343 | insertion | Frame_Shift_Ins | novel | c.1793_1794insGAGAGGGGCAAAGATGT | p.Phe599ArgfsTer59 | p.F599Rfs*59 | protein_coding | TCGA-A8-A06X-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |||
ZNF343 | insertion | Frame_Shift_Ins | novel | c.1440_1441insG | p.Arg481GlufsTer9 | p.R481Efs*9 | protein_coding | TCGA-A8-A0A4-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Hormone Therapy | tamoxiphen | CR | |||
ZNF343 | insertion | Nonsense_Mutation | novel | c.1439_1440insAAATTAGGTAAAGTGATTCAGATTAAAGGTGAAATAATTTATACA | p.Cys480delinsTer | p.C480delins* | protein_coding | TCGA-A8-A0A4-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Hormone Therapy | tamoxiphen | CR | |||
ZNF343 | SNV | Missense_Mutation | novel | c.213N>A | p.Phe71Leu | p.F71L | protein_coding | deleterious(0.01) | probably_damaging(0.999) | TCGA-C5-A8XJ-01 | Cervix | cervical & endocervical cancer | Female | >=65 | I/II | Chemotherapy | cisplatin | SD | |
ZNF343 | SNV | Missense_Mutation | novel | c.143N>T | p.Cys48Phe | p.C48F | protein_coding | tolerated(0.09) | benign(0.029) | TCGA-A6-6780-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 |
Top |
Related drugs of malignant transformation related genes |
Identification of chemicals and drugs interact with genes involved in malignant transfromation |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |